Your browser doesn't support javascript.
loading
Geriatric assessment-identified deficits in older cancer patients with normal performance status.
Jolly, Trevor A; Deal, Allison M; Nyrop, Kirsten A; Williams, Grant R; Pergolotti, Mackenzi; Wood, William A; Alston, Shani M; Gordon, Brittaney-Belle E; Dixon, Samara A; Moore, Susan G; Taylor, W Chris; Messino, Michael; Muss, Hyman B.
Afiliação
  • Jolly TA; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Deal AM; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Nyrop KA; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Williams GR; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Pergolotti M; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Wood WA; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Alston SM; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Gordon BB; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Dixon SA; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Moore SG; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Taylor WC; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Messino M; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
  • Muss HB; Hematology and Oncology Division and Center for Aging and Health/Division of Geriatric Medicine, School of Medicine, Lineberger Comprehensive Cancer Center, and Gillings School of Global Public Health, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina, USA; Rex Hematology Oncolo
Oncologist ; 20(4): 379-85, 2015 Apr.
Article em En | MEDLINE | ID: mdl-25765876
ABSTRACT

BACKGROUND:

We investigated whether a brief geriatric assessment (GA) would identify important patient deficits that could affect treatment tolerance and care outcomes within a sample of older cancer patients rated as functionally normal (80%-100%) on the Karnofsky performance status (KPS) scale.

METHODS:

Cancer patients aged ≥65 years were assessed using a brief GA that included both professionally and patient-scored KPS and measures of comorbidity, polypharmacy, cognition, function, nutrition, and psychosocial status. Data were analyzed using descriptive statistics and multivariable logistic regression.

RESULTS:

The sample included 984 patients mean age was 73 years (range 65-99 years), 74% were female, and 89% were white. GA was conducted before (23%), during (41%), or after (36%) treatment. Overall, 54% had a breast cancer diagnosis (n = 528), and 46% (n = 456) had cancers at other sites. Moreover, 81% of participants (n = 796) had both professionally and self-rated KPS ≥80, defined as functionally normal, and those patients are the focus of analysis. In this subsample, 550 (69%) had at least 1 GA-identified deficit, 222 (28%) had 1 deficit, 140 (18%) had 2 deficits, and 188 (24%) had ≥3 deficits. Specifically, 43% reported taking ≥9 medications daily, 28% had decreased social activity, 25% had ≥4 comorbidities, 23% had ≥1 impairment in instrumental activities of daily living, 18% had a Timed Up and Go time ≥14 seconds, 18% had ≥5% unintentional weight loss, and 12% had a Mental Health Index score ≤76.

CONCLUSION:

Within this sample of older cancer patients who were rated as functionally normal by KPS, GA identified important deficits that could affect treatment tolerance and outcomes.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação Geriátrica / Avaliação de Estado de Karnofsky / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Avaliação Geriátrica / Avaliação de Estado de Karnofsky / Neoplasias Tipo de estudo: Prognostic_studies Limite: Aged / Aged80 / Female / Humans / Male Idioma: En Ano de publicação: 2015 Tipo de documento: Article